Search clinical trials for: Letrozole -Berberine

Total 750 results

HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
China National Center for Cardiovascular Diseases

Not yet recruiting

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus (ABCD)

Hypertension | Dyslipidemias | PreDiabetes | Abdominal Obesity

China
Institut du Cancer de Montpellier - Val d'Aurelle
Novartis

Completed

Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer

Breast Cancer

France
Xijing Hospital of Digestive Diseases

Unknown

Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis

Ulcerative Colitis
University of Alabama at Birmingham
Genentech, Inc.; Breast Cancer Research Foundation

Completed

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Breast Cancer | Breast Neoplasm | Cancer of the Breast

United States
Guangdong Provincial People's Hospital

Unknown

The Therapeutic Effects of Insulin and Berberine on Stress Hyperglycemia

Hyperglycemia

China
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Breast Neoplasms
IVI Madrid

Active, not recruiting

Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors. (LETRODON)

Luteinised Follicular Cyst

Spain
Fudan University

Recruiting

Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP

Endometrial Cancer

China
Assiut University

Recruiting

Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

Infertility, Female

Egypt
Cairo University
Ahmed Elgazzar Hospital

Completed

Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

Infertility

Egypt
Genor Biopharma Co., Ltd.

Recruiting

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Breast Cancer

China
Tianjin Anding Hospital

Completed

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

Schizophrenia | Therapeutics
Novartis Pharmaceuticals

Completed

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

Breast Neoplasm

United States, Germany, Spain, United Kingdom, France, Austria, Russian Federation, Italy, Canada, Belgium
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
National Polytechnic Institute, Mexico
Instituto Nacional de Pediatria

Completed

Gymnema Sylvestre vs Berberine in Obesity Gene Expression of Adipokines (GS VS BBR A)

Obesity | Diabetes Mellitus
Affiliated Hospital of Nantong University

Not yet recruiting

Obinutuzumab in Chinese Real-world Patients With iNHL

Lymphomas Non-Hodgkin's B-Cell

China
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd.

Recruiting

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

T2DM (Type 2 Diabetes Mellitus)

China
Ahon Pharmaceutical Co., Ltd.

Recruiting

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Advanced Breast Cancer | Female Breast Cancer

China
Peking University People's Hospital

Unknown

Combination of Danazole With Berberine in the Treatment of ITP

Corticosteroid-resistant or Relapsed ITP

China
Dana-Farber Cancer Institute
Novartis; Brigham and Women's Hospital

Completed

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Leiomyosarcoma

United States
Carol Fabian, MD
Novartis

Completed

Protocol for Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Technical University of Munich

Withdrawn

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Breast Cancer

Germany
Rijnstate Hospital

Completed

Short-term Effects of Aromatase Inhibition in Obese Men

Obesity | Hypogonadotrophic Hypogonadism

Netherlands
MedSIR
Pfizer

Completed

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - (DxCARTES)

Breast Cancer

Spain, Portugal
Yuhan Corporation

Completed

Bioequivalence Study of Letrozole 2.5 mg Tablets

Healthy
Dartmouth-Hitchcock Medical Center

Recruiting

Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NAOMI)

Breast Cancer | ER Positive Breast Cancer

United States
NCIC Clinical Trials Group

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Breast Cancer

United States, Canada
Danish Breast Cancer Cooperative Group
Novartis; Danish Cancer Society; The Danish Medical Research Council

Terminated

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer (REAL)

Operable Breast Neoplasms

Denmark
Genor Biopharma Co., Ltd.

Recruiting

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
National Taiwan University Hospital

Unknown

Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle? (IVF/ICSI)

Reproductive Techniques, Assisted | Investigative Techniques | Reproductive Techniques

Taiwan
The University of Hong Kong
Queen Mary Hospital, Hong Kong; Kowloon Hospital, Hong Kong; Castle Peak Hospital and other collaborators

Completed

Berberine as Adjuvant Treatment for Schizophrenia Patients (BER)

Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Metabolic Syndrome x

Hong Kong
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Breast Cancer

United States
The Affiliated Hospital of Qingdao University

Not yet recruiting

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Neoplasms | Breast Cancer | Breast Diseases

China
Tanta University

Recruiting

Vitamin D and Calcium Supplementation in Breast Cancer

Breast Cancer

Egypt
Cairo University

Completed

Ovulation Induction in Clomiphene Citrate Resistant PCO Women

Polycystic Ovary Syndrome | Infertility

Egypt
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Obesity | Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Swiss GO Trial Group
Hoffmann-La Roche; Novartis Pharmaceuticals; AGO Study Group; Anticancer Fund,... and other collaborators

Recruiting

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) (MATAO)

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Neoplasm Epithelial | High-grade Serous Ovarian Carcinoma (HGSOC) | Low-grade Serous Ovarian Carcinoma (LGSOC) | Ovarian Endometrioid Carcinoma

Austria, Switzerland, Germany
American University of Beirut Medical Center

Withdrawn

Aromatase Inhibitors for Treatment of Uterine Leiomyomas

Symptomatic or Large Uterine Fibroids

Lebanon
Egymedicalpedia

Completed

Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Egypt
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

Breast Cancer

United Kingdom
Sheba Medical Center

Unknown

Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve

Infertility

Israel
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaborators

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Fibrolamellar Carcinoma | Fibrolamellar Liver Cancer

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Platinum-resistant Recurrent Ovarian Cancer

China
Beni-Suef University

Completed

Letrozole Dose Increments in PCOS Patients Resistant to Letrozole

Polycystic Ovary Syndrome

Egypt
Zagazig University

Completed

Evaluation of Different Doses of Letrozole in Ectopic Pregnancy (letrezole)

Ectopic Pregnancy

Egypt
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Obesity | Atypical Endometrial Hyperplasia | Progesterone Resistance

China
UNICANCER

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (LIBER)

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation Carrier

France
EQRx International, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Withdrawn

Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

Endometrial Carcinoma

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

Breast Cancer

United States

Search clinical trials for: Letrozole -Berberine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations